Cargando…

Substance P Receptor Signaling Mediates Doxorubicin-Induced Cardiomyocyte Apoptosis and Triple-Negative Breast Cancer Chemoresistance

Doxorubicin (DOX), an anthracycline, is broadly considered the most active single agent available for treating breast cancer but has been known to induce cardiotoxicity. Although DOX is highly effective in treating triple-negative breast cancer (TNBC), DOX can have poor outcomes owing to induction o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Robinson, Prema, Kasembeli, Moses, Bharadwaj, Uddalak, Engineer, Nikita, Eckols, Kris T., Tweardy, David J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766315/ https://www.ncbi.nlm.nih.gov/pubmed/26981525 http://dx.doi.org/10.1155/2016/1959270

Ejemplares similares

Contribution of STAT3 to Inflammatory and Fibrotic Diseases and Prospects for its Targeting for Treatment
por: Kasembeli, Moses M., et al.
Publicado: (2018)

Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution
por: Bharadwaj, Uddalak, et al.
Publicado: (2020)

Therapeutic Potential of a Small-Molecule STAT3 Inhibitor in a Mouse Model of Colitis
por: Robinson, Prema, et al.
Publicado: (2023)

Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2016)

Correction: Small-molecule inhibition of STAT3 in radioresistant head and neck squamous cell carcinoma
por: Bharadwaj, Uddalak, et al.
Publicado: (2019)

Genetic and Small-Molecule Modulation of Stat3 in a Mouse Model of Crohn’s Disease
por: Robinson, Prema, et al.
Publicado: (2022)

Aberrant function of pathogenic STAT3 mutant proteins is linked to altered stability of monomers and homodimers
por: Kasembeli, Moses M., et al.
Publicado: (2023)

Modulation of STAT3 Folding and Function by TRiC/CCT Chaperonin
por: Kasembeli, Moses, et al.
Publicado: (2014)

Substance P Causes Seizures in Neurocysticercosis
por: Robinson, Prema, et al.
Publicado: (2012)

Modulation of the Unfolded Protein Response During Hepatocyte and Cardiomyocyte Apoptosis In Trauma/Hemorrhagic Shock
por: Thacker, Stephen A., et al.
Publicado: (2013)

DRUG-REPOSITIONING SCREENING IDENTIFIED PIPERLONGUMINE AS A DIRECT STAT3 INHIBITOR WITH POTENT ACTIVITY AGAINST BREAST CANCER
por: Bharadwaj, Uddalak, et al.
Publicado: (2014)

Substance P Antagonism Prevents Chemotherapy-Induced Cardiotoxicity
por: Legi, Ashiq, et al.
Publicado: (2021)

Chemical Probes that Competitively and Selectively Inhibit Stat3 Activation
por: Xu, Xuejun, et al.
Publicado: (2009)

Blockade of the PD-1/PD-L1 Immune Checkpoint Pathway Improves Infection Outcomes and Enhances Fungicidal Host Defense in a Murine Model of Invasive Pulmonary Mucormycosis
por: Wurster, Sebastian, et al.
Publicado: (2022)

Substance P Signaling Contributes to Granuloma Formation in Taenia crassiceps Infection, a Murine Model of Cysticercosis
por: Garza, Armandina, et al.
Publicado: (2010)

Substance P prevents doxorubicin-induced cardiomyocyte injury by regulating apoptosis and autophagy: In vitro and in vivo evidence
por: Chen, Fa-Xiu, et al.
Publicado: (2022)

Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis
por: Rodriguez, Emma, et al.
Publicado: (2021)

Contribution of the Type II Chaperonin, TRiC/CCT, to Oncogenesis
por: Roh, Soung-Hun, et al.
Publicado: (2015)

Substance P Receptor Antagonism: A Potential Novel Treatment Option for Viral-Myocarditis
por: Robinson, Prema, et al.
Publicado: (2015)

The fate of chemoresistance in triple negative breast cancer (TNBC)
por: O’Reilly, Elma A., et al.
Publicado: (2015)

High expression of apoptosis protein (Api-5) in chemoresistant triple-negative breast cancers: an innovative target
por: Bousquet, Guilhem, et al.
Publicado: (2019)

Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer
por: Yuan, Shen-Jun, et al.
Publicado: (2019)

eIF4A/PDCD4 Pathway, a Factor for Doxorubicin Chemoresistance in a Triple-Negative Breast Cancer Cell Model
por: González-Ortiz, Alina, et al.
Publicado: (2022)

Overexpression of angiopoietin-1 reduces doxorubicin-induced apoptosis in cardiomyocytes
por: Ren, Danyang, et al.
Publicado: (2012)

Hydroxytyrosol Prevents Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes
por: Sirangelo, Ivana, et al.
Publicado: (2022)

Novel strategies to target chemoresistant triple-negative breast cancer
por: Venkatesh, Jaganathan, et al.
Publicado: (2020)

DSTYK Enhances Chemoresistance in Triple-Negative Breast Cancer Cells
por: Ogbu, Stella C., et al.
Publicado: (2021)

Soft Tissue Sarcoma Study: Association of Genetic Alterations in the Apoptosis Pathways with Chemoresistance to Doxorubicin
por: Kirilin, Evgeny M., et al.
Publicado: (2022)

Role of ABCB1 in mediating chemoresistance of triple-negative breast cancers
por: Abd El-Aziz, Yomna S., et al.
Publicado: (2021)

Erratum: Rodriguez et al. Substance P Antagonism as a Novel Therapeutic Option to Enhance Efficacy of Cisplatin in Triple Negative Breast Cancer and Protect PC12 Cells against Cisplatin-Induced Oxidative Stress and Apoptosis. Cancers 2021, 13, 3871
por: Rodriguez, Emma, et al.
Publicado: (2021)

Chemoresistance in the Human Triple-Negative Breast Cancer Cell Line MDA-MB-231 Induced by Doxorubicin Gradient Is Associated with Epigenetic Alterations in Histone Deacetylase
por: Han, Jeonghun, et al.
Publicado: (2019)

Curcumin Downregulates Phosphate Carrier and Protects against Doxorubicin Induced Cardiomyocyte Apoptosis
por: Junkun, Lu, et al.
Publicado: (2016)

Doxorubicin induces cardiotoxicity through upregulation of death receptors mediated apoptosis in cardiomyocytes
por: Zhao, Liqun, et al.
Publicado: (2017)

Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis
por: Khumbatta, Mitra, et al.
Publicado: (2014)

Corrigendum to “Somatostatin Negatively Regulates Parasite Burden and Granulomatous Responses in Cysticercosis”
por: Khumbatta, Mitra, et al.
Publicado: (2015)

Rosmarinic acid alleviates cardiomyocyte apoptosis via cardiac fibroblast in doxorubicin-induced cardiotoxicity
por: Zhang, Xin, et al.
Publicado: (2019)

Piperlongumine Induces Apoptosis and Synergizes with Doxorubicin by Inhibiting the JAK2-STAT3 Pathway in Triple-Negative Breast Cancer
por: Chen, Di, et al.
Publicado: (2019)

Albumin nanoformulations as an innovative solution to overcome doxorubicin chemoresistance
por: Bessone, Federica, et al.
Publicado: (2021)

Antitumor Activity of Noscapine in Combination with Doxorubicin in Triple Negative Breast Cancer
por: Chougule, Mahavir B., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_i91990lpugjo3g0lh7lekrnfcv